1. ESC, 2013 http://www.scardio.ru/content/Guidelines/Rek_infarct_2013
2. Российский кардиологический журнал, 2013; 2(100), прил. 1.
3. Рекомендации по реваскуляризации миокарда Европейского общества кардиологов, 2010.
4. Ведение больных со стабильной стенокардией, рекомендации РКО, ESC, 2009.
5. Рациональная фармакотерапия в кардиологии 2011; Прил. 3.
6. European Heart Journal (2010) 31, 2501–2555 doi:10.1093/eurheartj/ehq277 (http://cardiocity.ru/sites/default/files/rek/guidelines-revasc-FT.pdf).
7. Рациональная фармакотерапия в кардиологии, 2009; 5.
8. Рекомендации ЕОК по лечению инфаркта миокарда со стойким подъемом сегмента ST. 2011.
9. Schomig A, Mehilli J, de Waha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 894–904.
10. Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double–vessel versus single–vessel coronary artery dis–ease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS. J Am Coll Cardiol 1997; 29: P1505–11.
11. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions // Circulation. 2011. Vol. 124(23). P. e574–e651.
12. Рекомендации Европейского общества кардиологов по острому коронарному синдрому без подъема сегмента ST 2011 г.
13. Рациональная Фармакотерапия в Кардиологии 2012; Прил. 2
14. Рекомендации по ведению ХСН «Сердечная недостаточность», 11, 1 (57), 2010
15. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST–segment elevation. Eur Heart J 2012. 33 (20): 2569–619.
16. Bhatt DL, Chew DP, Hirsch AT et al. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation, 2001; 103: 363–8.
17. Chen W-H, Lee PY, Ng W et al. Prevalence, profile, and predictors of aspirin resistance measured by the Ultegra rapid platelet function assay-ASA in patients with coronary artery disease J Am Coll Cardiol. 2005; 45: 382A.
18. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006; 27: 647–54.